Bibliography
- De Wet P. Motsoaledi: big pharma’s ‘satanic’ plot is genocide. Mail & Guardian. 2014. Available from: http://bit.ly/LnpIMj [Last accessed 29 March 2014]
- Love J. New leaked Merck missive reveals deep drug, medical device company opposition to South African patent reforms. Knowledge Ecology International. 2014. Available from: http://www.keionline.org/node/1908 [Last accessed 29 March 2014]
- UNAIDS. 2013 Regional Report – Getting to zero: HIV in Eastern and Southern Africa. UNAIDS, Geneva; 2013. Available from: http://catalogue.safaids.net/sites/default/files/publications/Getting-to-Zero-2013.pdf [Last accessed 2 April 2014]
- Ndjeka N. Multi-drug resistant tuberculosis: strategic overview on MDR-TB care in South Africa. The Department of Health. MSF, Johannesburg; 2014. Available from: http://bit.ly/1s87Lly [Last accessed 30 March 2014]
- Bradshaw D, Steyn K, Levitt N, Nojilana B. Non-communicable diseases – A race against time. Medical Research Council, MRC, Cape Town; 2011. Available from: http://www.mrc.ac.za/policybriefs/raceagainst.pdf [Last accessed 30 March 2014]
- Benatar S. The challenges of health disparities in South Africa. S Afr Med J 2013.103(3):154-5. Available from: http://www.samj.org.za/index.php/samj/article/view/6622/4918 [Last accessed 30 March 2014]
- The Department of Trade and Industry. Draft National Policy on Intellectual Property (IP) of South Africa. DTI, Pretoria; 2013. Available from: www.gov.za/documents/download.php?f=198116 [Last accessed 30 March 2014]
- MSF, TAC, SECTION27. Joint Submission on the Draft National Intellectual Property Policy, 2013. Fix the Patent Laws. 2013. Available from: http://bit.ly/1cMXNxM [Last accessed 30 March 2014]
- ‘t Hoen E. The Global Politics of Pharmaceutical Monopoly Power. AMB, Diemen; 2009. Available from: http://bit.ly/1lC4Z6O [Last accessed 30 March 2014]
- Minister of Health v New Clicks South Africa (Pty) Ltd. CCT 59/2004 [2005] ZACC 14; 2006 (8) BCLR 872 (CC); 2006 (2) SA 311 (CC) at paragraph 514. Constitutional Court of South Africa. 2005. Available from: http://www.saflii.org.za/za/cases/ZACC/2005/14.html [Last accessed 30 March 2014]
- Park C, Prabhala A, Berger J. Using law to accelerate treatment access in South Africa: an analysis of patent, competition and medicines law. United Nations Development Programme, New York; 2013. Available from: http://www.undp.org/content/dam/undp/library/hivaids/English/using_law_to_accelerate_treatment_access_in_south_africa_undp_2013.pdf [Last accessed 30 March 2014]
- Registration Procedure, 2011. Companies and Intellectual Property Commission. CIPC, Pretoria; 2011. Available from: http://www.cipc.co.za/Patents_RegProcedure.aspx [Last accessed 30 March 2014]
- Correa CM. Pharmaceutical innovation, incremental patenting and compulsory licensing, South Centre. 2011. Available from: www.law.fsu.edu/events/documents/Correa.docx [Last accessed 30 March 2014]
- Kapczynski A, Park C, Sampat B. South African Pharmaceutical Patenting: an empirical analysis. Fix the patent laws. Yale Law School; Medicines Patent Pool; Dept. of Health Policy & Management, Columbia University. 2012. Available from: http://bit.ly/1ec8DMK [Last accessed 30 March 2014]
- Novartis AG. Pyrimidine derivatives and process for the preparation thereof. ZA1993/02397. 1993. Available from: http://bit.ly/1hDVqkl [Last accessed 30 March 2014]
- Novartis AG. Treatment of gastrointestinal stromal tumours. ZA2003/02155. 2003. Available from: http://bit.ly/1k2ESWK [Last accessed 30 March 2014]
- SA’s Dept of Trade & Industry delays patent law reform. Doctors Without Borders South Africa. MSF, Pretoria; 2013. Available from: http://bit.ly/PmuoDM [Last accessed 29 March 2014]
- Patents (Amendment) Act, 2005 (Act No. 15 of 2005). Ministry of Law and Justice, New Delhi; 2005. Available from: http://www.wipo.int/wipolex/en/details.jsp?id=2407 [Last accessed 29 March 2014]
- Joint Resolution 118/2012, 546/2012 and 107/2012: Adoption of Guidelines for Patentability Examination of Patent Applications for Chemical and Pharmaceutical Inventions. Ministry of Industry, Ministry of Health, National Industrial Property Institute, Buenos Aires; 2012. Available from: http://www.wipo.int/wipolex/en/details.jsp?id=13007 [Last accessed 30 March 2014]
- Argentina: análisis de patentes farmacéuticas concedidas en 2012. Cámara Industrial de Laboratoríos Farmacéuticos Argentinos. CILFA, Buenos Aires; 2013. Available from: http://bit.ly/1jYJo8v [Last accessed 30 March 2014]
- Baker B. Economics of the Pharmaceutical Industry. University of Kwa-Zulu Natal-IP and Access to Medicines. Northeastern University School of Law, Health GAP (Global Access Project). 2010. Available from: http://tinyurl.com/kls7sjd [Last accessed 29 March 2014]
- Røttingen JA, Chamas CI, Correa CM, et al. Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. WHO, Geneva; 2012. Available from: http://www.who.int/phi/CEWG_Report_5_April_2012.pdf?ua=1 [Last accessed 30 March 2014]
- Gokhale K. Merck to bristol-myers face threats on India patents (Correct). Bloomberg Businessweek. Bloomberg L.P., New York; 2014. Available from: http://buswk.co/1aWH3qL [Last accessed 30 March 2014]
- Mkhwanazi S, Curling-Hope M. MPs set to tackle vital patent legislation on medicines. The New Age. TNA Media (Pty.) Ltd. 2014. Available from: http://bit.ly/1cQwTmZ [Last accessed 30 March 2014]